Sugi Predict

Sugi Predict / Compounds / SCHEMBL184762

SCHEMBL184762

SCHEMBL184762

CCC(C)c1[c]c(C(C)CC)ccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.41
▸ HDAC4 P56524 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.31
▸ ALOX15 P16050 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ TRPA1 O75762 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249427 0.93 TSHR (0.38) TSHRHDAC4HDAC2HDAC8
SCHEMBL8074869 0.87 TSHR (0.36) TSHRHDAC4HDAC2HDAC8TRPA1
SCHEMBL16440037 0.85 TSHR (0.35) TSHRHDAC4HDAC2HDAC8
SCHEMBL2776672 0.85 TSHR (0.35) TSHRHDAC4HDAC2HDAC8
SCHEMBL16440057 0.85 TSHR (0.35) TSHRHDAC4HDAC2HDAC8
SCHEMBL2696941 0.85 TSHR (0.35) TSHRHDAC4HDAC2HDAC8
SCHEMBL11503835 0.82 TSHR (0.33) TSHRHDAC4HDAC2HDAC8
SCHEMBL11503678 0.82 GABRA1 (0.34) TSHRHDAC4HDAC2HDAC8
SCHEMBL11504243 0.82 TSHR (0.33) TSHRHDAC4HDAC2HDAC8RORC
SCHEMBL11504390 0.80 TSHR (0.32) TSHRHDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216900-A1 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-07-04 — — US claimed
WO-2024060641-A1 CYCLOTRIARYLPHOSPHINE, METHOD FOR PREPARING SAME, AND USE THEREOF 东莞市均成高新材料有限公司 2024-03-28 — — WO claimed
WO-2023196594-A2 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-10-12 — — WO claimed
CN-115850329-A Cycloterpyriaryl phosphines, their preparation and use 东莞市均成高新材料有限公司 2023-03-28 — — CN claimed
CN-115385956-A Biaryl diphosphine ligands and transition metal complexes thereof 东莞市均成高新材料有限公司 2022-11-25 — — CN claimed
CN-115385955-A Tetrabiarylphosphine ligands and transition metal complexes thereof 东莞市均成高新材料有限公司 2022-11-25 — — CN claimed
CN-115385957-A Linear terphenyl aryl phosphine ligand and transition metal complex thereof 东莞市均成高新材料有限公司 2022-11-25 — — CN claimed
CN-112876516-A N- (4-indolyl) N-heterocyclic carbene palladium complex and application thereof 昆明理工大学 2021-06-01 — — CN claimed
EP-0555351-A1 OXYSULFONYL CARBAMATES. WARNER LAMBERT CO (US) 1993-08-18 — — EP claimed
EP-0150967-B1 PROCESS FOR PRODUCING 4,4'-DIHYDROXYDIPHENYLS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1989-04-12 — — EP claimed
US-20240216900-A1 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-07-04 — — US disclosed
WO-2023196594-A2 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-10-12 — — WO disclosed
WO-2023196602-A1 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-10-12 — — WO disclosed
EP-3018118-B1 BASE GENERATOR, BASE-REACTIVE COMPOSITION CONTAINING SAID BASE GENERATOR, AND BASE GENERATION METHOD FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2023-07-05 — — EP disclosed
EP-4182395-A1 DITHIOLENE METAL COMPLEXES BASF SE (DE) 2023-05-24 — — EP disclosed
EP-0682081-A1 Flame-retardant resin composition DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1995-11-15 — — EP disclosed
US-5405962-A Quaterrylenetetracarbimides BASF AKTIENGESELLSCHAFT (DE) 1995-04-11 — — US disclosed
EP-0596292-A1 Quaterrylene tetracarboxylic imides BASF Aktiengesellschaft (DE) 1994-05-11 — — EP disclosed
US-4169106-A Antiarrhythmic N,N'-bis(phenylcarbamoylalkyl)amidines COOPER LABORATORIES, INC. (US) 1979-09-25 — — US disclosed
US-4137273-A INSECTICIDES, CHEMICAL INTERMEDIATES ZOECON CORPORATION (US) 1979-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216900-A1 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS FABP7, FFAR1, FABP1 TSHR 112/4885HDAC4 2241/4885HDAC2 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.